CN Stock MarketDetailed Quotes

603207 Shanghai Xiao Fang Pharmaceutical

Watchlist
  • 25.81
  • -0.07-0.27%
Not Open Nov 28 15:00 CST
4.13BMarket Cap20.98P/E (TTM)

Shanghai Xiao Fang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Assets
Current assets
Money funds
--852.01M
--346.08M
386.76%285.54M
----
----
30.91%58.66M
--81.45M
-13.93%44.81M
315.07%52.06M
--12.54M
Transactional financial assets
----
----
-97.27%2.97M
----
----
-31.08%108.96M
--151.11M
160.79%158.11M
332.57%60.63M
--14.02M
Notes receivable and accounts receivable
--95.69M
--115.79M
4.29%85.39M
----
----
46.67%81.88M
--114.84M
-20.25%55.82M
-0.54%70M
--70.38M
-Notes receivable
--500K
----
----
----
----
----
----
-44.34%138.47K
-13.83%248.78K
--288.69K
-Accounts receivable
--95.19M
--115.79M
4.29%85.39M
----
----
47.03%81.88M
--114.84M
-20.17%55.69M
-0.48%69.75M
--70.09M
Other receivables (including interest and dividends)
--663.26K
--599.88K
160.56%644.96K
----
----
-19.97%247.53K
--225.5K
-90.82%309.29K
177.33%3.37M
--1.21M
-Other receivable
----
--599.88K
----
----
----
-19.97%247.53K
--225.5K
-90.82%309.29K
177.33%3.37M
--1.21M
Advance payment
--7.49M
--7.07M
-2.66%10.72M
----
----
83.52%11.02M
--5.59M
50.93%6M
-40.95%3.98M
--6.74M
Inventories
--41.57M
--40.57M
-12.76%49.9M
----
----
7.17%57.2M
--50.3M
32.70%53.37M
-5.83%40.22M
--42.71M
Non-current assets due within one year
----
----
----
----
----
-74.33%1.31M
--5.15M
--5.08M
----
----
Other current assets
--1.36M
--15.29M
96.43%16.88M
----
----
201.10%8.59M
--6.18M
683.23%2.85M
-99.60%364.45K
--90.12M
Total current assets
--998.78M
--525.41M
37.88%452.06M
----
----
0.46%327.87M
--414.85M
41.51%326.37M
-2.98%230.63M
--237.72M
Non Current assets
Debt investment
----
----
----
----
----
----
--1.29M
-79.45%1.27M
--6.19M
----
Fixed assets
----
--8.56M
----
----
----
3.00%11.71M
--11.91M
-17.51%11.37M
11.78%13.79M
--12.33M
Constru in process
----
--269.03M
----
----
----
294.82%50.04M
--13.45M
1,634.37%12.67M
--730.77K
----
Intangible assets
--24.93M
--25.32M
-5.73%26.12M
----
----
-5.21%27.7M
--28.44M
-5.13%29.23M
--30.81M
----
Long deferred expense
--1.38M
--1.2M
-3.18%470.22K
----
----
-34.20%485.64K
--611.87K
19.16%738.1K
--619.4K
----
Deferred tax assets
--3.28M
--2.49M
25.68%2.86M
----
----
13.85%2.27M
--1.9M
38.80%2M
7.55%1.44M
--1.34M
Usufruct assets
--504.93K
--605.91K
-33.33%807.88K
----
----
-28.94%1.21M
--1.41M
--1.71M
----
----
Other non current assets
--1.39M
--9.24M
-89.10%4.58M
----
----
6,197.45%42M
--2.25M
74.65%667K
--381.9K
----
Total non current assets
--352.55M
--316.46M
92.41%260.59M
----
----
127.04%135.43M
--61.26M
10.56%59.65M
294.67%53.95M
--13.67M
Total assets
--1.35B
42.95%841.87M
53.82%712.65M
23.69%588.92M
--502.88M
20.02%463.3M
--476.11M
35.65%386.02M
13.20%284.58M
--251.39M
Liabilities
Current liabilities
Notes payable and accounts payable
--24.21M
--20.52M
-28.48%19.61M
----
----
65.10%27.42M
--25.23M
-24.91%16.61M
23.54%22.12M
--17.9M
-Accounts payable
--24.21M
--20.52M
-28.48%19.61M
----
----
65.10%27.42M
--25.23M
-24.91%16.61M
23.54%22.12M
--17.9M
Contract liabilities
--501.81K
--598.57K
-60.50%610.61K
----
----
-86.89%1.55M
--707.26K
816.78%11.79M
--1.29M
----
Advance receipts
----
----
----
----
----
----
----
----
----
--1.32M
Salaries payable
--5.99M
--5.63M
-9.06%6.76M
----
----
-4.12%7.43M
--9.09M
-11.36%7.75M
18.56%8.74M
--7.37M
Taxs payable
--10.11M
--13.17M
-65.11%5.76M
----
----
-30.23%16.52M
--23.23M
-6.52%23.68M
14.22%25.33M
--22.18M
Other payable (including interest and dividends)
--116.98M
--100.43M
175.88%97.21M
----
----
-62.05%35.24M
--128.73M
811.31%92.86M
15.13%10.19M
--8.85M
-Dividend payable
----
----
----
----
----
----
--111.39M
--75.39M
----
----
-Other payable
----
--100.43M
----
----
----
--35.24M
----
----
--10.19M
----
Non current liabilities due within one year
--549.67K
--657.13K
9.73%422.22K
----
----
-14.67%384.79K
--393.83K
--450.97K
----
--385.26K
Other current liabilities
--2.38M
--1.39M
26.58%1.8M
----
----
-40.91%1.42M
--1.02M
102.11%2.41M
--1.19M
----
Total current liabilities
--160.72M
--142.4M
46.92%132.18M
----
----
-42.16%89.96M
--188.4M
125.90%155.55M
18.71%68.86M
--58.01M
Current liabilities
Long term deferred income
--68.57K
--71.79K
-14.12%78.21K
----
----
-12.37%91.07K
--97.5K
-11.01%103.93K
--116.79K
----
Lease liabilities
--112.5K
--223.7K
-49.90%442.27K
----
----
-30.36%882.77K
--1.07M
--1.27M
----
----
Total non current liabilities
--181.07K
--295.49K
-46.55%520.49K
----
----
-28.99%973.84K
--1.17M
1,074.37%1.37M
--116.79K
----
Total liabilities
--160.9M
49.16%142.7M
45.92%132.7M
-49.53%95.67M
--74.58M
-42.05%90.94M
--189.56M
127.51%156.92M
18.91%68.97M
--58.01M
Shareholders equity
Paid-in capital
--160M
--120M
0.00%120M
----
----
0.00%120M
--120M
275.00%120M
0.00%32M
--32M
Capital reserve funds
--478.03M
--69.62M
6.08%69.22M
----
----
6.66%65.25M
--63.03M
24,612.51%61.18M
0.00%247.56K
--247.56K
Surplus reserve funds
--42.62M
--42.62M
91.45%42.62M
----
----
369.26%22.26M
--4.74M
-70.35%4.74M
0.00%16M
--16M
Retained profit
--509.79M
--466.93M
111.18%348.12M
----
----
281.73%164.85M
--98.77M
-74.20%43.18M
15.31%167.36M
--145.14M
Shareholders equity without minority interests
--1.19B
41.75%699.17M
55.75%579.95M
72.14%493.25M
--428.3M
62.53%372.36M
--286.55M
6.26%229.11M
11.49%215.61M
--193.38M
Total shareholder equity
--1.19B
41.75%699.17M
55.75%579.95M
72.14%493.25M
--428.3M
62.53%372.36M
--286.55M
6.26%229.11M
11.49%215.61M
--193.38M
Total liabilityies and equity
--1.35B
42.95%841.87M
53.82%712.65M
23.69%588.92M
--502.88M
20.02%463.3M
--476.11M
35.65%386.02M
13.20%284.58M
--251.39M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
Unqualified opinion
--
Unqualified opinion
Unqualified opinion
Unqualified opinion
Auditor
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Assets
Current assets
Money funds --852.01M--346.08M386.76%285.54M--------30.91%58.66M--81.45M-13.93%44.81M315.07%52.06M--12.54M
Transactional financial assets ---------97.27%2.97M---------31.08%108.96M--151.11M160.79%158.11M332.57%60.63M--14.02M
Notes receivable and accounts receivable --95.69M--115.79M4.29%85.39M--------46.67%81.88M--114.84M-20.25%55.82M-0.54%70M--70.38M
-Notes receivable --500K-------------------------44.34%138.47K-13.83%248.78K--288.69K
-Accounts receivable --95.19M--115.79M4.29%85.39M--------47.03%81.88M--114.84M-20.17%55.69M-0.48%69.75M--70.09M
Other receivables (including interest and dividends) --663.26K--599.88K160.56%644.96K---------19.97%247.53K--225.5K-90.82%309.29K177.33%3.37M--1.21M
-Other receivable ------599.88K-------------19.97%247.53K--225.5K-90.82%309.29K177.33%3.37M--1.21M
Advance payment --7.49M--7.07M-2.66%10.72M--------83.52%11.02M--5.59M50.93%6M-40.95%3.98M--6.74M
Inventories --41.57M--40.57M-12.76%49.9M--------7.17%57.2M--50.3M32.70%53.37M-5.83%40.22M--42.71M
Non-current assets due within one year ---------------------74.33%1.31M--5.15M--5.08M--------
Other current assets --1.36M--15.29M96.43%16.88M--------201.10%8.59M--6.18M683.23%2.85M-99.60%364.45K--90.12M
Total current assets --998.78M--525.41M37.88%452.06M--------0.46%327.87M--414.85M41.51%326.37M-2.98%230.63M--237.72M
Non Current assets
Debt investment --------------------------1.29M-79.45%1.27M--6.19M----
Fixed assets ------8.56M------------3.00%11.71M--11.91M-17.51%11.37M11.78%13.79M--12.33M
Constru in process ------269.03M------------294.82%50.04M--13.45M1,634.37%12.67M--730.77K----
Intangible assets --24.93M--25.32M-5.73%26.12M---------5.21%27.7M--28.44M-5.13%29.23M--30.81M----
Long deferred expense --1.38M--1.2M-3.18%470.22K---------34.20%485.64K--611.87K19.16%738.1K--619.4K----
Deferred tax assets --3.28M--2.49M25.68%2.86M--------13.85%2.27M--1.9M38.80%2M7.55%1.44M--1.34M
Usufruct assets --504.93K--605.91K-33.33%807.88K---------28.94%1.21M--1.41M--1.71M--------
Other non current assets --1.39M--9.24M-89.10%4.58M--------6,197.45%42M--2.25M74.65%667K--381.9K----
Total non current assets --352.55M--316.46M92.41%260.59M--------127.04%135.43M--61.26M10.56%59.65M294.67%53.95M--13.67M
Total assets --1.35B42.95%841.87M53.82%712.65M23.69%588.92M--502.88M20.02%463.3M--476.11M35.65%386.02M13.20%284.58M--251.39M
Liabilities
Current liabilities
Notes payable and accounts payable --24.21M--20.52M-28.48%19.61M--------65.10%27.42M--25.23M-24.91%16.61M23.54%22.12M--17.9M
-Accounts payable --24.21M--20.52M-28.48%19.61M--------65.10%27.42M--25.23M-24.91%16.61M23.54%22.12M--17.9M
Contract liabilities --501.81K--598.57K-60.50%610.61K---------86.89%1.55M--707.26K816.78%11.79M--1.29M----
Advance receipts --------------------------------------1.32M
Salaries payable --5.99M--5.63M-9.06%6.76M---------4.12%7.43M--9.09M-11.36%7.75M18.56%8.74M--7.37M
Taxs payable --10.11M--13.17M-65.11%5.76M---------30.23%16.52M--23.23M-6.52%23.68M14.22%25.33M--22.18M
Other payable (including interest and dividends) --116.98M--100.43M175.88%97.21M---------62.05%35.24M--128.73M811.31%92.86M15.13%10.19M--8.85M
-Dividend payable --------------------------111.39M--75.39M--------
-Other payable ------100.43M--------------35.24M----------10.19M----
Non current liabilities due within one year --549.67K--657.13K9.73%422.22K---------14.67%384.79K--393.83K--450.97K------385.26K
Other current liabilities --2.38M--1.39M26.58%1.8M---------40.91%1.42M--1.02M102.11%2.41M--1.19M----
Total current liabilities --160.72M--142.4M46.92%132.18M---------42.16%89.96M--188.4M125.90%155.55M18.71%68.86M--58.01M
Current liabilities
Long term deferred income --68.57K--71.79K-14.12%78.21K---------12.37%91.07K--97.5K-11.01%103.93K--116.79K----
Lease liabilities --112.5K--223.7K-49.90%442.27K---------30.36%882.77K--1.07M--1.27M--------
Total non current liabilities --181.07K--295.49K-46.55%520.49K---------28.99%973.84K--1.17M1,074.37%1.37M--116.79K----
Total liabilities --160.9M49.16%142.7M45.92%132.7M-49.53%95.67M--74.58M-42.05%90.94M--189.56M127.51%156.92M18.91%68.97M--58.01M
Shareholders equity
Paid-in capital --160M--120M0.00%120M--------0.00%120M--120M275.00%120M0.00%32M--32M
Capital reserve funds --478.03M--69.62M6.08%69.22M--------6.66%65.25M--63.03M24,612.51%61.18M0.00%247.56K--247.56K
Surplus reserve funds --42.62M--42.62M91.45%42.62M--------369.26%22.26M--4.74M-70.35%4.74M0.00%16M--16M
Retained profit --509.79M--466.93M111.18%348.12M--------281.73%164.85M--98.77M-74.20%43.18M15.31%167.36M--145.14M
Shareholders equity without minority interests --1.19B41.75%699.17M55.75%579.95M72.14%493.25M--428.3M62.53%372.36M--286.55M6.26%229.11M11.49%215.61M--193.38M
Total shareholder equity --1.19B41.75%699.17M55.75%579.95M72.14%493.25M--428.3M62.53%372.36M--286.55M6.26%229.11M11.49%215.61M--193.38M
Total liabilityies and equity --1.35B42.95%841.87M53.82%712.65M23.69%588.92M--502.88M20.02%463.3M--476.11M35.65%386.02M13.20%284.58M--251.39M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion----Unqualified opinion--Unqualified opinionUnqualified opinionUnqualified opinion
Auditor ----PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)----PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data